Results 201 to 210 of about 146,874 (392)

Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-Institutional Phase II Trial [PDF]

, 2004
Karen L. Tedesco, Ann D. Thor, Douglas H. Johnson, Yu Shyr, K. A. Blum, Lori J. Goldstein, William J. Gradishar, Brenda P. Nicholson, Douglas E. Merkel, D. Murrey, S. Edgerton, George W. Sledge   +11 more
openalex   +1 more source

Tumour Cell Size Control and Its Impact on Tumour Cell Function

Cell Proliferation, EarlyView.
The regulatory mechanism of the size of tumour cells and its impact on the functions of tumour cells, as well as a summary of potential therapeutic targets for the corresponding mechanisms. ABSTRACT Cell size is an important component of cell morphological characteristics.
Min Zhou, Mei Zhou, Yang Jin
wiley   +1 more source

Her2 and Trastuzumab in Breast Cancer

, 2001
John Horton
openalex   +1 more source

P27kip1 Down-Regulation Is Associated with Trastuzumab Resistance in Breast Cancer Cells [PDF]

, 2004
Rita Nahta, Takeshi Takahashi, Naoto T. Ueno, Mien‐Chie Hung, Francisco J. Esteva   +4 more
openalex   +1 more source

Liquid–Liquid Phase Separation in Major Hallmarks of Cancer

Cell Proliferation, EarlyView.
Aberrant condensates formed through phase separation are involved in the dysregulation of various critical cellular processes, including genome stability, transcriptional regulation and signal transduction, thereby promoting malignant transformation and the acquisition of multiple cancer hallmarks.
Chen‐chen Xie, Ting Wang, Xin‐ran Liu, Yan Wang, Qin Dang, Tian Ding, Jia‐qi Xu, Xian‐jun Yu, Hai Lin, Xiao‐wu Xu, Yi Qin   +10 more
wiley   +1 more source

Generation of Peptide Mimics of the Epitope Recognized by Trastuzumab on the Oncogenic Protein Her-2/neu [PDF]

, 2004
Angelika B. Riemer, Markus Klinger, Stephan N. Wagner, Astrid Bernhaus, Luca Mazzucchelli, Hubert Pehamberger, Otto Scheiner, Christoph Zielinski, Erika Jensen‐Jarolim   +8 more
openalex   +1 more source

Barriers to adoption of biosimilar insulins in Europe: A mixed‐methods study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Background Despite the introduction of biosimilar insulins to improve affordability and enhance patient access, their adoption remains limited in Europe. Objectives This study aims to (i) provide an up‐to‐date overview of EMA‐approved insulin products and their reimbursement status across selected European countries, and (ii) explore the k,ey ...
Elif Car, Garm Habets, Arnold G. Vulto, Lutz Heinemann, Isabelle Huys, Steven Simoens   +5 more
wiley   +1 more source

A Novel Peptide Isolated from a Phage Display Peptide Library with Trastuzumab Can Mimic Antigen Epitope of HER-2 [PDF]

, 2004
Beihai Jiang, Wenbin Liu, Hong Qu, Meng Lin, Shumei Song, Tao Ouyang, Chengchao Shou   +6 more
openalex   +1 more source

Clinical experience with lapatinib in patients with ErbB2-overexpressing metastatic breast cancer [PDF]

, 2008
Blackwell KL, Burris, Christianson TA, Clayton AJ, Di Leo A, Lin NU, Michael Untch, Nadia Harbeck, Rusnak DW, Schwartz G, Sibylle Loibl, Stemmler J, Storniolo A, Volker Heinemann   +13 more
core   +3 more sources

Effects of trastuzumab and trastuzumab-emtansine on QTc intervals

Cardiologia Croatica, 2018
Martina Lovrić Benčić, Lada Bradić, Rea Levicki, Juraj Jug, Marta Begovac, Marina Mihajlović   +5 more
openaire   +1 more source